DK0604114T3 - 5,6-kondenserende, heterocykliske diarylsyrer som leukotrienantagonister - Google Patents

5,6-kondenserende, heterocykliske diarylsyrer som leukotrienantagonister

Info

Publication number
DK0604114T3
DK0604114T3 DK93310127T DK93310127T DK0604114T3 DK 0604114 T3 DK0604114 T3 DK 0604114T3 DK 93310127 T DK93310127 T DK 93310127T DK 93310127 T DK93310127 T DK 93310127T DK 0604114 T3 DK0604114 T3 DK 0604114T3
Authority
DK
Denmark
Prior art keywords
diarylic
acids
leukotriene antagonists
condensing
heterocyclic
Prior art date
Application number
DK93310127T
Other languages
English (en)
Inventor
Cheuk K Lau
Yi Bin Xiang
Marc Labelle
Yves Leblanc
Claude Dufresne
Yves Gareau
Robert N Young
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Application granted granted Critical
Publication of DK0604114T3 publication Critical patent/DK0604114T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93310127T 1992-12-22 1993-12-15 5,6-kondenserende, heterocykliske diarylsyrer som leukotrienantagonister DK0604114T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99486992A 1992-12-22 1992-12-22

Publications (1)

Publication Number Publication Date
DK0604114T3 true DK0604114T3 (da) 2000-08-07

Family

ID=25541163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93310127T DK0604114T3 (da) 1992-12-22 1993-12-15 5,6-kondenserende, heterocykliske diarylsyrer som leukotrienantagonister

Country Status (23)

Country Link
EP (1) EP0604114B1 (da)
KR (1) KR100310552B1 (da)
CN (1) CN1040213C (da)
AT (1) ATE192448T1 (da)
AU (1) AU672837B2 (da)
CA (1) CA2111372C (da)
CZ (1) CZ290829B6 (da)
DE (1) DE69328540T2 (da)
DK (1) DK0604114T3 (da)
ES (1) ES2145765T3 (da)
FI (1) FI111368B (da)
GR (1) GR3033985T3 (da)
HU (1) HU222274B1 (da)
IL (1) IL108050A (da)
MX (1) MX9400022A (da)
NO (1) NO313831B1 (da)
NZ (1) NZ258835A (da)
PL (1) PL177967B1 (da)
PT (1) PT604114E (da)
RU (1) RU2154065C2 (da)
SK (1) SK282409B6 (da)
WO (1) WO1994014815A1 (da)
ZA (1) ZA939560B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472964A (en) * 1992-12-22 1995-12-05 Merck Frosst Canada, Inc. Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
US5350760A (en) * 1993-08-04 1994-09-27 Merck Frosst Canada, Inc. Aza-5,5-fused hetrocyclic acids as leukotriene antagonists
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
US5427933A (en) * 1994-07-20 1995-06-27 Merck & Co., Inc. Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
US5491077A (en) * 1994-07-20 1996-02-13 Merck & Co., Inc. Microbial method
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5750539A (en) * 1995-06-07 1998-05-12 Merck Frosst Canada Heteroaryl diol acids as leukotriene antagonists
RU2196772C1 (ru) * 2001-10-08 2003-01-20 Кубанский государственный технологический университет 6-МЕТИЛ-8-МЕТОКСИМЕТИЛ-3-ФЕНИЛИЗОКСАЗОЛО[3',4':4,5]ТИЕНО-[2,3-b]ПИРИДИН, ПРОЯВЛЯЮЩИЙ РОСТОРЕГУЛИРУЮЩУЮ И АНТИСТРЕССОВУЮ АКТИВНОСТЬ
CN1318400C (zh) * 2002-02-06 2007-05-30 戴尔玛化学品股份有限公司 制备1－(巯基甲基)－环丙烷乙酸的方法
US7271268B1 (en) 2006-12-22 2007-09-18 Formosa Laboratories Inc. Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives
RU2449807C2 (ru) * 2009-11-16 2012-05-10 Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" Способ лечения эндотоксикоза при хроническом пиелонефрите

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001576A1 (fr) * 1982-10-07 1984-04-26 Takeda Chemical Industries Ltd Derives de pyrrolidone fondus
US4957932A (en) * 1987-11-25 1990-09-18 Merck Frosst Canada, Inc. Benzoheterazoles
CA2053216C (en) * 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
ATE165088T1 (de) * 1990-10-12 1998-05-15 Merck Frosst Canada Inc Ungesättigte hydroxyalkylchinolinsäuren als leukotrien-antagonisten
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
SK82295A3 (en) 1995-12-06
EP0604114A1 (en) 1994-06-29
DE69328540D1 (de) 2000-06-08
NO952495L (no) 1995-08-22
HU222274B1 (hu) 2003-05-28
CZ290829B6 (cs) 2002-10-16
FI953104A0 (fi) 1995-06-21
SK282409B6 (sk) 2002-01-07
PT604114E (pt) 2000-09-29
FI953104L (fi) 1995-06-21
NZ258835A (en) 1997-06-24
CA2111372C (en) 2007-01-16
NO952495D0 (no) 1995-06-21
ES2145765T3 (es) 2000-07-16
PL177967B1 (pl) 2000-02-29
ZA939560B (en) 1994-08-11
IL108050A0 (en) 1994-04-12
FI111368B (fi) 2003-07-15
PL309408A1 (en) 1995-10-02
KR100310552B1 (ko) 2001-12-17
NO313831B1 (no) 2002-12-09
DE69328540T2 (de) 2001-01-04
HU9501842D0 (en) 1995-08-28
RU2154065C2 (ru) 2000-08-10
WO1994014815A1 (en) 1994-07-07
AU672837B2 (en) 1996-10-17
AU5257993A (en) 1994-07-07
CN1094051A (zh) 1994-10-26
HUT71810A (en) 1996-02-28
MX9400022A (es) 1995-01-31
RU95113598A (ru) 1997-06-10
IL108050A (en) 1998-06-15
CZ165395A3 (en) 1996-01-17
EP0604114B1 (en) 2000-05-03
GR3033985T3 (en) 2000-11-30
CN1040213C (zh) 1998-10-14
KR950704325A (ko) 1995-11-17
ATE192448T1 (de) 2000-05-15
CA2111372A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
DE69129257D1 (de) Ungesättigte Hydroxyalkylchinolinsäuren als Leukotrien-Antagonisten
FI944734A0 (fi) Kinoliinijohdannaiset leukotrieeniantagonisteina
NO920681D0 (no) Kinolinholdige ketosyrer som leukotrien-antagonister
DK0604114T3 (da) 5,6-kondenserende, heterocykliske diarylsyrer som leukotrienantagonister
NO914003D0 (no) Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrer
WO1995004741A1 (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists